Concern grows as US data shows hit to diagnosis and treatment

The decline in diagnostic testing in the US - which is also evident in Australia - reflects a significant fall in oncology and other patient interactions. The fear is that this will delay treatment for many patients and could ultimately lead to higher costs and mortality. …